Full Text View
Tabular View
No Study Results Posted
Related Studies
Intranasal Oxytocin for the Treatment of Autism Spectrum Disorders (INOT)
This study is currently recruiting participants.
Verified November 2012 by Montefiore Medical Center
Study NCT01337687   Information provided by Montefiore Medical Center

First Received on December 15, 2010.   Last Updated on November 5, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Autism Spectrum Disorders
Additional conditions recognized in this trial
Autistic Disorder
Child Development Disorders, Pervasive
More general conditions related to this trial
Mental Disorders
Mental Disorders Diagnosed in Childhood
Interventions listed in this trial
Intranasal Oxytocin
Placebo
Additional drug interventions recognized in this trial
Oxytocin
More general drug interventions related to this trial
Oxytocics
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
Montefiore Medical Center
National Alliance for Research on Schizophrenia and Depression


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services